BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 19016777)

  • 1. Hepatitis B virus infection is dependent on cholesterol in the viral envelope.
    Bremer CM; Bung C; Kott N; Hardt M; Glebe D
    Cell Microbiol; 2009 Feb; 11(2):249-60. PubMed ID: 19016777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of glycosaminoglycans for binding and infection of hepatitis B virus.
    Leistner CM; Gruen-Bernhard S; Glebe D
    Cell Microbiol; 2008 Jan; 10(1):122-33. PubMed ID: 18086046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficient infection of primary tupaia hepatocytes with purified human and woolly monkey hepatitis B virus.
    Köck J; Nassal M; MacNelly S; Baumert TF; Blum HE; von Weizsäcker F
    J Virol; 2001 Jun; 75(11):5084-9. PubMed ID: 11333889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Canine distemper virus infection requires cholesterol in the viral envelope.
    Imhoff H; von Messling V; Herrler G; Haas L
    J Virol; 2007 Apr; 81(8):4158-65. PubMed ID: 17267508
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Entry of hepatitis B virus: mechanism and new therapeutic target.
    Xie Y; Zhai J; Deng Q; Tiollais P; Wang Y; Zhao M
    Pathol Biol (Paris); 2010 Aug; 58(4):301-7. PubMed ID: 20570056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated expression of bisecting N-acetylglucosaminyltransferase-III gene in a human fetal hepatocyte cell line by hepatitis B virus.
    Shim JK; Lee YC; Chung TH; Kim CH
    J Gastroenterol Hepatol; 2004 Dec; 19(12):1374-87. PubMed ID: 15610311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducible high level infection of cultured adult human hepatocytes by hepatitis B virus: effect of polyethylene glycol on adsorption and penetration.
    Gripon P; Diot C; Guguen-Guillouzo C
    Virology; 1993 Feb; 192(2):534-40. PubMed ID: 8421898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus mutations associated with fulminant hepatitis induce apoptosis in primary Tupaia hepatocytes.
    Baumert TF; Yang C; Schürmann P; Köck J; Ziegler C; Grüllich C; Nassal M; Liang TJ; Blum HE; von Weizsäcker F
    Hepatology; 2005 Feb; 41(2):247-56. PubMed ID: 15660384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of hepatitis B virus-infected cells with alpha-glucosidase inhibitors results in production of virions with altered molecular composition and infectivity.
    Lazar C; Durantel D; Macovei A; Zitzmann N; Zoulim F; Dwek RA; Branza-Nichita N
    Antiviral Res; 2007 Oct; 76(1):30-7. PubMed ID: 17548120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies to inhibit entry of HBV and HDV into hepatocytes.
    Urban S; Bartenschlager R; Kubitz R; Zoulim F
    Gastroenterology; 2014 Jul; 147(1):48-64. PubMed ID: 24768844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus.
    Jaoudé GA; Sureau C
    J Virol; 2005 Aug; 79(16):10460-6. PubMed ID: 16051838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein.
    Gripon P; Cannie I; Urban S
    J Virol; 2005 Feb; 79(3):1613-22. PubMed ID: 15650187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the cytosolic domains of the hepatitis B virus envelope proteins for their function in viral particle assembly and infectivity.
    Blanchet M; Sureau C
    J Virol; 2006 Dec; 80(24):11935-45. PubMed ID: 17020942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ezetimibe blocks hepatitis B virus infection after virus uptake into hepatocytes.
    Lucifora J; Esser K; Protzer U
    Antiviral Res; 2013 Feb; 97(2):195-7. PubMed ID: 23266293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between desialylated hepatitis B virus and asialoglycoprotein receptor on hepatocytes may be indispensable for viral binding and entry.
    Owada T; Matsubayashi K; Sakata H; Ihara H; Sato S; Ikebuchi K; Kato T; Azuma H; Ikeda H
    J Viral Hepat; 2006 Jan; 13(1):11-8. PubMed ID: 16364077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attachment sites and neutralising epitopes of hepatitis B virus.
    Glebe D
    Minerva Gastroenterol Dietol; 2006 Mar; 52(1):3-21. PubMed ID: 16554703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein.
    Petersen J; Dandri M; Mier W; Lütgehetmann M; Volz T; von Weizsäcker F; Haberkorn U; Fischer L; Pollok JM; Erbes B; Seitz S; Urban S
    Nat Biotechnol; 2008 Mar; 26(3):335-41. PubMed ID: 18297057
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of hepatitis B virus with cells.
    Paran N; Cooper A; Shaul Y
    Rev Med Virol; 2003; 13(3):137-43. PubMed ID: 12740829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement of cholesterol in the viral envelope for dengue virus infection.
    Carro AC; Damonte EB
    Virus Res; 2013 Jun; 174(1-2):78-87. PubMed ID: 23517753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP.
    Iwamoto M; Watashi K; Tsukuda S; Aly HH; Fukasawa M; Fujimoto A; Suzuki R; Aizaki H; Ito T; Koiwai O; Kusuhara H; Wakita T
    Biochem Biophys Res Commun; 2014 Jan; 443(3):808-13. PubMed ID: 24342612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.